Skip to content
DataLookout
Menu

NCT04031950

Clinical Evaluation of a Paediatric Sleep Diagnosis Technology

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 1 year 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 10 versions: 10 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates pushed to Oct 14, 2027 Show 6 more changesShow less
    • Enrollment increased: 200 → 345 participants
    • Eligibility criteria expanded, about 52 words
    • Trial arms changed: 2 → 5
    • Study description expanded, about 188 words
    • Site details revised at 1 of 2 sites
    • Collaborators: details revised at 1 of 2 entries
  2. Notable Primary completion date: Dec 30, 2023 to Oct 30, 2025
    • Study completion date: Dec 30, 2023 to Dec 30, 2025
    v9
  3. Notable Primary and study completion dates: Jun 30, 2023 to Dec 30, 2023
    • Study sites: 1 to 2
    v8
  4. Notable Primary and study completion dates: Jun 30, 2022 to Jun 30, 2023
    • Enrollment target: 150 to 200
    • Collaborators: 1 to 2
    v7
  5. Notable Primary and study completion dates pushed to Jun 30, 2022v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Primary completion date: Nov 30, 2020 to Nov 30, 2021
    • Study completion date: Dec 30, 2020 to Dec 30, 2021
    v5
  2. Minor Site contact updatedv4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 25, 2020 to Feb 19, 2020
    • Site details revised
    v3
  4. Notable Start date: Nov 1, 2019 to Jan 25, 2020
    • Site contact updated
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Specificity and sensitivity of novel device
Timeframe: 6 months

Arms and interventions

test group

Test group will wear PSG

Novel wearable device

THis group will wear the novel device

Home

40 consecutive patients (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who will have been referred for at home diagnosis of sleep apnoea or overnight oximetry at home. Each site will recruit, in parallel, consecutive patients from the moment the first patient in this group is recruited at that site. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 8 years old and referral for overnight assessment for evaluation of possible sleep apnoea. Additionally, patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. This patient cohort will be used to assess the acceptance of the AcuPebble technology in the home environment.

Ventilation

30 patients will be recruited (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who are on mechanical ventilation and have been referred for diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 1 year old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study in hospital, or over 8 years old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study at home. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of diagnostic validity.

High BMI

75 patients will be recruited (plus/minus 30% to account for potential dropouts, or invalid signals from the gold-standard), who have a BMI SDS score of 3 or more and have been referred for either at-home or in-hospital diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. If their study is to take place in the home, only children who are older than 8 will be included. If their study is to take place in hospital, children over the age of 1 will be included. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of sensitivity and specificity for this cohort.

Devices: Novel wearable paediatric device

Sites

2 sites in 1 country